BMJ

CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis

5 Department of Orthopedic Surgery and Department of Bioengineering, Stanford University, Stanford, California, USA Correspondence to Dr William H Robinson, Division of Immunology and Rheumatology, ...
BMJ

Mechanisms of bone erosion in gout: a quantitative analysis using plain radiography and computed tomography

Bone Research Group and Auckland Rheumatology Imaging Group, University of Auckland, Auckland, New Zealand Dr N Dalbeth, Bone Research Group, Department of Medicine, Faculty of Medical and Health ...
BMJ

EULAR recommendations for the treatment of systemic sclerosis: 2023 update

Objectives To update the 2017 European Alliance of Associations for Rheumatology (EULAR) recommendations for treatment of systemic sclerosis (SSc), incorporating new evidence and therapies. Methods An ...
BMJ

Table of contents

F8: Back to the future: how to mix the old and new treatments for SLE, Sjögren's and APS ...
BMJ

Assessing the performance of AI chatbots in answering patients’ common questions about low back pain

Objectives The aim of this study was to assess the accuracy and readability of the answers generated by large language model (LLM)-chatbots to common patient questions about low back pain (LBP).
BMJ

Real-life use of the PEXIVAS reduced-dose glucocorticoid regimen in granulomatosis with polyangiitis and microscopic polyangiitis

3 Centre de Recherche en Epidémiologie et Statistiques (CRESS), Unité Inserm 1153, Université Paris Cité, Paris, France ...
BMJ

Relationship between serum urate and changes in dual-energy CT monosodium urate crystal volume over 1 year in people with gout: an individual participant data analysis

Objectives The dynamics of monosodium urate (MSU) crystal changes across a range of serum urate concentrations in people with gout are unknown. This study aimed to systematically examine the ...
BMJ

CD-19 CAR-T cells for polyrefractory rheumatoid arthritis

‘Poly-refractory’ disease affects 2.7% of patients with rheumatoid arthritis (RA) who have failed different groups of biologic disease-modifying antirheumatic drugs (b-DMARDS) and targeted synthetic ...
BMJ

Vascular occlusion for optimising the functional improvement in patients with knee osteoarthritis: a randomised controlled trial

Objectives Knee osteoarthritis (KOA) is a leading cause of global disability with conventional exercise yielding only modest improvements. Here we aimed to investigate the benefits of integrating ...
BMJ

Protein kinase R is highly expressed in dermatomyositis and promotes interferon-beta-induced muscle damage

Objectives Dermatomyositis (DM) has been consistently linked to the type I interferon (IFN-I) pathway. However, the precise pathogenesis remains incompletely elucidated. We aimed to explore potential ...
BMJ

Suprascapular nerve block (using bupivacaine and methylprednisolone acetate) in chronic shoulder pain

Correspondence to: Dr M Shanahan, Rheumatology Research Unit, Repatriation General Hospital, Daw Park, South Australia, Australia 5041; michael.shanahan{at}rgh.sa.gov.au. Background: Shoulder pain ...
BMJ

The number of flares patients experience impacts on damage accrual in systemic lupus erythematosus: data from a multiethnic Latin American cohort

Correspondence to Bernardo A Pons-Estel, Hospital Provincial de Rosario, Rosario, Argentina, Avenida del Huerto 1375, Rosario, 2000, Argentina; baponsestel{at}buenaventuraguarani.com.ar Purpose To ...